Tolerable upper intake levels for trans fat, saturated fat, and cholesterol

Nutrition Reviews

Volumn 69, Issue 5, 2011, Pages 270-278

  Trumbo, Paula R ^a   Shimakawa, Tomoko ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cholesterol; Saturated fatty acid; Tolerable upper intake levels; Trans fatty acids

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRANS FATTY ACID;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); FAT INTAKE; HIGH RISK POPULATION; RISK ASSESSMENT;

CHOLESTEROL, DIETARY; CHRONIC DISEASE; DIETARY FATS; FATTY ACIDS; HUMANS; MAXIMUM TOLERATED DOSE; NUTRITION POLICY; TRANS FATTY ACIDS;

EID: 79955394409     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00389.x     Document Type: Article

References (40)

1. National Research Council. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Research Council/National Academy Press; 1989. Available at: Accessed 9 April 2010.
2. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge: Harvard University Press; 1980.
3. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate. Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: Institute of Medicine of the National Academies/National Academy Press; 2005. Available at: Accessed 9 April 2010.
4. Institute of Medicine. The Development of DRIs 1994-2004: Lessons Learned and New Challenges. Washington, DC: Institute of Medicine of the National Academies/National Academy Press; 2008. Available at: Accessed 9 April 2010.
5. World Health Organization/Food and Agriculture Organization of the United Nations. A Model for Establishing Upper Levels of Intake for Nutrients and Related Substances. Geneva: World Health Organization; 2006.
6. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans. 2010. Available at: Accessed 23 March 2011.
7. Hu FB, Manson JE, Willett WC. Types of fat and risk of coronary heart disease: a critical review. J Am Coll Med. 2001;20:5-19.
8. Jakobsen M, O'Reilly EJ, Heitmann BL, etal. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425-1432.
9. U.S. Food and Drug Administration. Food labeling; reference daily intakes and daily reference values. Final rule. Fed Regist. 1993;58:2206-2228.
10. U.S. Department of Health and Human Services. The Surgeon General's Report on Nutrition and Health. Washington, DC; 1988. Available at Accessed 23 March 2011.
11. rd ed. Washington, DC: Home and Gardening Bulletin No. 232. U.S. Government Printing Office; 1990.
12. Tardiff JC, Heinonen T, Orloff D, Libby P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation. 2006;113:2936-2942.
13. Institute of Medicine. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: Institute of Medicine of the National Academies/National Academy Press; 2010.
14. Noakes M, Clifton PM. Oil blends containing partially hydrogenated or interesterified fats: differential effects on plasma lipids. Am J Clin Nutr. 1998;68:242-247.
15. Judd JT, Clevidence BA, Muesung RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr. 1994;59:861-868.
16. Cuchel M, Schwab US, Jones PJH, etal. Impact of hydrogenated fat consumption on endogenous cholesterol synthesis and susceptibility of low-density lipoprotein to oxidation in moderately hypercholesterolemic individuals. Metabolism. 1996;45:241-247.
17. Nestel P, Noakes M, Belling B, etal. Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res. 1992;33:1029-1036.
18. Judd JT, Baer DJ, Clevidence BA, Kris-Etherton P, Muesing RA, Iwane M. Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men. Lipids. 2002;37:123-131.
19. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med. 1999;340:1933-1940.
20. Lovejoy JC, Smith SR, Champagne CM, etal. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care. 2002;25:1283-1288.
21. Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. Trans (elaidic) fatty acids adversely effect the lipoprotein profile relative to saturated fatty acids in humans. J Nutr. 1997;127(Suppl):S514-S520.
22. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323:439-445.
23. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: Institute of Medicine of the National Academies/National Academy Press; 2010.
24. Rothman KJ, Moore LL, Singer MR, Nguyen UDT, Mannino S, Milunsky B. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333:1369-1373.
25. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow-up study in the United States. BMJ. 1996;313:84-90.
26. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ. 2003;327:1-6.
27. Willett WC, Stampfer MJ, Manson JE, etal. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581-585.
28. Hu FB, Stampfer MJ, Manson JE, etal. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491-1499.
29. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol. 2005;161:672-679.
30. Pietinen P, Ascherio A, Korhonen P, etal. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. Am J Epidemiol. 1997;145:876-887.
31. Oomen CM, Ocke MC, Feskens EJM, van Erp-Baart MAJ, Kok FJ, Kromhout D. Assocation between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;357:746-751.
32. Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr. 1993;57:875-883.
33. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. Br Med J. 1997;314:112-117.
34. Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res. 1995;36:1370-1384.
35. de Roos NM, Schouten EG, Katan MB. Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J Nutr. 2001;131:242-245.
36. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res. 1992;33:399-410.
37. Aro A, Jauhiainen M, Partanen R, Salminen I, Mutanen M. Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoprotein lipids, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr. 1997;65:1419-1426.
38. Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated fats vegetable oils with other fats and oils. Eur J Clin Nutr. 2009;63(Suppl):S22-S33.
39. Kris-Etherton PM, Shaomei Y. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 1997;65(Suppl):S1628-S1644.
40. Leosdottir M, Nilsson PM, Nilsson JA, Berglund G. Cardiovascular event risk in relation to dietary fat intake in middle-age individuals: data from the Malmö Diet and Cancer Study. Eur Soc Cardiol. 2007;14:701-706.